PATENT CLAIM ANALYSIS

Application Number: 15778199
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "019300"]

Abstract:
The present invention relates to novel peptides derived from solute carrier family 45 member 2 (SLC45A2), complexes comprising such peptides bound to recombinant MHC molecules, and cells presenting said peptide in complex with MHC molecules. Also provided by the present invention are binding moieties that bind to the peptides and/or complexes of the invention. Such moieties are useful for the development of immunotherapeutic reagents for the treatment of diseases such as cancer.

Claim (Index 13):
A polypeptide as defined in any one of  claims 1 - 3 , a complex as defined in  claim 4  or  claim 5 , a nucleic acid molecule as defined in  claim 6 , a vector as defined in  claim 7 , a cell as defined in  claim 8  or a binding moiety as defined in any one of  claims 9 - 12  for use in medicine.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 93.0
- Lexical Diversity: 1.41071
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15460654', '12666416', '13946313', '15213991', '13731711']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7531154356021729
- 35 USC 102 Novelty (BERT): 0.5312200328955337
- Combined Prediction Score: 0.730925895331509
- Mean Citation Score: 288.740294
- Max Citation Score: 300.89285
- Similarity Product: 174.36470433122517

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test